Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Mycobacterium tuberculosis | Probable polypeptide deformylase Def (PDF) (formylmethionine deformylase) | 0.0978 | 1 | 0.5 |
Trypanosoma brucei | Peptide deformylase 2 | 0.0373 | 0.1223 | 0.5 |
Brugia malayi | Trypsin family protein | 0.033 | 0.0592 | 0.5 |
Mycobacterium leprae | PROBABLE POLYPEPTIDE DEFORMYLASE DEF (PDF) (FORMYLMETHIONINE DEFORMYLASE) | 0.0978 | 1 | 0.5 |
Trypanosoma cruzi | polypeptide deformylase-like protein, putative | 0.0373 | 0.1223 | 0.5 |
Toxoplasma gondii | hypothetical protein | 0.0978 | 1 | 0.5 |
Wolbachia endosymbiont of Brugia malayi | peptide deformylase | 0.0978 | 1 | 0.5 |
Trypanosoma cruzi | polypeptide deformylase-like protein, putative | 0.0373 | 0.1223 | 0.5 |
Trypanosoma cruzi | Peptide deformylase 2, putative | 0.0373 | 0.1223 | 0.5 |
Mycobacterium ulcerans | peptide deformylase | 0.0978 | 1 | 0.5 |
Trypanosoma cruzi | Peptide deformylase 2, putative | 0.0373 | 0.1223 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.033 | 0.0592 | 0.5 |
Treponema pallidum | polypeptide deformylase (def) | 0.0978 | 1 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.033 | 0.0592 | 0.5 |
Schistosoma mansoni | subfamily S1A unassigned peptidase (S01 family) | 0.033 | 0.0592 | 0.5 |
Plasmodium vivax | peptide deformylase, putative | 0.0978 | 1 | 0.5 |
Onchocerca volvulus | 0.033 | 0.0592 | 1 | |
Leishmania major | polypeptide deformylase-like protein, putative | 0.0373 | 0.1223 | 0.5 |
Plasmodium falciparum | peptide deformylase | 0.0978 | 1 | 0.5 |
Schistosoma mansoni | subfamily S1A unassigned peptidase (S01 family) | 0.033 | 0.0592 | 0.5 |
Trypanosoma brucei | Polypeptide deformylase 1 | 0.0373 | 0.1223 | 0.5 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.